Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference
FRIENDSWOOD, Texas, Nov. 11, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Piper Sandler 38th Annual...
Covered in this story
Analyst targets on Castle Biosciences Inc
- Mizuho: at $38.5 · target $60 by Oct 2027 · Outperform via Investing.com
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CSTL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Castle Biosciences Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.